Edwards Lifesciences (EW) EBT Margin (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly EBT Margin of 27.84% for Q1 2026, down 287.0% year-over-year from 14.89% in Q1 2025, and up 383.41% quarter-over-quarter from 5.76% in Q4 2025.
Edwards Lifesciences (EW) EBT Margin (2009 - 2026) Analysis & Trends
Edwards Lifesciences' EBT Margin history runs 18 years deep, the most recent figure standing at 27.84% for Q1 2026.
- In Q1 2026, EBT Margin fell 287.0% year-over-year to 27.84%; the TTM figure through Mar 2026 stood at 20.59% (down 858.0% YoY), while the FY2025 annual figure was 20.98%, down 748.0% from the prior year.
- EBT Margin for Q1 2026 stood at 27.84%, up from 5.76% in the prior quarter.
- The five-year high for EBT Margin was 49.17% in Q4 2022, with the low at 5.76% in Q4 2025.
- The 5-year median for EBT Margin is 29.0% (2023), against an average of 28.67%.
- The sharpest annual moves came in 2022 and 2025: EBT Margin soared 2087 bps in 2022, then slumped 2239 bps in 2025.
- Edwards Lifesciences' EBT Margin stood at 49.17% in 2022, then slumped by 41 bps to 29.0% in 2023, then slipped by 3 bps to 28.15% in 2024, then tumbled by 80 bps to 5.76% in 2025, then surged by 383 bps to 27.84% in 2026.
- Business Quant data shows EW's EBT Margin at 27.84% in Q1 2026, 5.76% in Q4 2025, and 22.43% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.32% |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 11.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.86% |
| Mar 31, 2026 | 27.84% |
| Dec 31, 2025 | 5.76% |
| Sep 30, 2025 | 22.43% |
| Jun 30, 2025 | 26.12% |
| Mar 31, 2025 | 30.71% |
| Dec 31, 2024 | 28.15% |
| Sep 30, 2024 | 29.74% |
| Jun 30, 2024 | 28.04% |
| Mar 31, 2024 | 27.91% |
| Dec 31, 2023 | 29.00% |
| Sep 30, 2023 | 31.17% |
| Jun 30, 2023 | 21.51% |
| Mar 31, 2023 | 32.64% |
| Dec 31, 2022 | 49.17% |
| Sep 30, 2022 | 30.88% |
| Jun 30, 2022 | 33.82% |
| Mar 31, 2022 | 32.52% |
| Dec 31, 2021 | 28.30% |
| Sep 30, 2021 | 29.84% |